Advanced Oncotherapy (AVO)

 

Latest News

Holding(s) in Company

RNS Number: 0037A Advanced Oncotherapy PLC 21 March 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Advanced Oncotherapy plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rig...

Hardman Research: Delivery of LIGHT

RNS Number: 4786Z Advanced Oncotherapy PLC 15 March 2017 Hardman Research: Delivery of LIGHT Delivery of LIGHT: AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an exciting stage with construction work on its Harl...

Posting of Circular, Notice of GM and Update

RNS Number: 0859Z Advanced Oncotherapy PLC 10 March 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Posting of Circular, Notice of General Meeting and Update on Financing Options Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a ...

Investor presentation and Update

RNS Number: 6494Y Advanced Oncotherapy PLC 06 March 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Investor presentation and Update Advanced Oncotherapy (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, will be hosting investor and analyst presentations in London later...

All News

DateHeadlineSource
21-03-17Holding(s) in CompanyRNS
15-03-17Hardman Research: Delivery of LIGHTRNS
10-03-17Posting of Circular, Notice of GM and UpdateRNS
06-03-17Investor presentation and UpdateRNS
28-02-17Conversion of convertible loan notesRNS
27-02-17Broker Forecast - Beaufort Securities issues a broker note on Advanced Oncotherapy PLCStockMarketWire
24-02-17Update on financing and Harley StreetRNS
22-02-17Advanced Oncotherapy financing deal with Bracknor StockMarketWire
22-02-17Financing agreementRNS
16-02-17Investor presentationRNS
09-02-17Advanced Oncotherapy strengthens its boardStockMarketWire
09-02-17Directorate ChangeRNS
08-02-17Significant shareholderRNS
06-02-17Sinophi updateRNS
26-01-17Directorate ChangesRNS
24-01-17Advanced Oncotherapy says Sinophi wants to terminate ordersStockMarketWire
24-01-17FTSE mixed ahead of Article 50 ruling as BT divesStockMarketWire
24-01-17Sinophi UpdateRNS
23-01-17Advanced Oncotherapy financing plan talks expanded StockMarketWire
23-01-17Non-dilutive financing plan updateRNS
03-01-17Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
03-01-17Director DealingRNS
29-12-16Director DealingRNS
29-12-16Significant Shareholding DealingRNS
22-12-16Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
22-12-16Director DealingRNS
22-12-16Advanced Oncotherapy progress on LIGHT system StockMarketWire
22-12-16Further progress in LIGHT technical developmentRNS
21-12-16Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
21-12-16Director DealingRNS
21-12-16Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
21-12-16Director DealingRNS
20-12-16Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
20-12-16Director dealingRNS
15-12-16Video of LIGHT system and testing facilitiesRNS
15-12-16Advanced Oncotherapy - LIGHT system testing facilitiesBRR Media
30-11-16Operational UpdateRNS
29-11-16Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
29-11-16Director Dealing - replacementRNS
29-11-16Director DealingRNS

RSS feeds

  • Editorial news feed for LSE:AVO Editorial
  • Regulatory news feed for LSE:AVO Regulatory